Baxter International Stock Intrinsic Value – Baxter International Reports Record-Breaking Q2 Earnings
July 28, 2023
🌥️Trending News
Baxter International ($NYSE:BAX), a leading global medical products company based in Deerfield, Illinois, reported record-breaking second-quarter earnings this week. This marks the fifth consecutive quarter of double-digit growth for the company, reflecting the strength of its diversified business model and its focus on delivering quality products and services to its customers. It manufactures and distributes a wide variety of products, including intravenous solutions, hemodialysis machines, nutrition products, and medical devices and supplies. The company also provides specialty pharmaceutical services to hospitals, long-term care facilities, and home-healthcare providers.
In addition, Baxter has been actively investing in research and development, exploring new technologies and advancing its portfolio of lifesaving treatments. With its record-breaking second quarter earnings, Baxter is well-positioned to continue delivering strong financial results in the coming quarters. Investors are encouraged by this news and have expressed optimism for the future of the company.
Earnings
In its earning report of FY2023 Q1 ending March 31 2021, BAXTER INTERNATIONAL reported record-breaking results, earning total revenue of 2946.0M USD and net income of 298.0M USD. Compared to the same period of the previous year, the total revenue decreased by 20.5%, while the net income showed a substantial growth of 319.7%. Furthermore, over the past three years, BAXTER INTERNATIONAL’s total revenue has risen from 2946.0M USD to 3649.0M USD.
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Baxter International. More…
| Total Revenues | Net Income | Net Margin |
| 15.05k | -2.46k | -4.7% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Baxter International. More…
| Operations | Investing | Financing |
| 1.48k | -797 | -1.26k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Baxter International. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 28.29k | 22.35k | 11.62 |
Key Ratios Snapshot
Some of the financial key ratios for Baxter International are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 9.3% | 2.0% | -12.8% |
| FCF Margin | ROE | ROA |
| 5.1% | -20.5% | -4.2% |
Market Price
This marked a drop of 7.1% from their last closing price of $49.0. The earnings report highlighted the success of the company’s healthcare solutions, which have been in high demand amidst the ongoing pandemic. It is expected that the company will continue to be successful in the coming quarters due to its innovative products and services. Additionally, the company has continued to expand its portfolio, making it well-positioned for future growth. Live Quote…
Analysis – Baxter International Stock Intrinsic Value
At GoodWhale, we have conducted a thorough analysis of BAXTER INTERNATIONAL‘s wellbeing and present our findings here. Our proprietary Valuation Line indicates that the fair value of the company’s stock is around $79.3, yet the current market price is trading at $45.5 – a difference of 42.7%! This suggests that BAXTER INTERNATIONAL’s stock is currently significantly undervalued, making it an attractive option for investors. More…
Peers
Baxter International Inc is a large medical device company. Its main competitors are Utah Medical Products Inc, Clarity Medical Group Holding Ltd, and Merit Medical Systems Inc.
– Utah Medical Products Inc ($NASDAQ:UTMD)
The company’s market cap is $313.74 million and its ROE is 11.43%. Utah Medical Products, Inc. engages in the design, manufacture, and marketing of medical devices. It operates through the following segments: Pregnancy & Newborn, Patient Care, and Animal Health. The Pregnancy & Newborn segment offers a line of products used by obstetricians, gynecologists, and neonatal caregivers for the health and well-being of pregnant women and their babies. The Patient Care segment provides a line of products used by hospitals, clinics, and home healthcare providers for the treatment of respiratory and other conditions. The Animal Health segment offers a line of products used by veterinarians for the health and well-being of animals.
– Clarity Medical Group Holding Ltd ($SEHK:01406)
According to Clarity Medical Group Holding Ltd’s market cap as of 2022, the company is worth 599.47 million. Clarity Medical Group Holding Ltd is a Medical Group that provides healthcare services. The company was founded in 2014 and is headquartered in Hong Kong.
– Merit Medical Systems Inc ($NASDAQ:MMSI)
Medstronic is a medical device company that manufactures and sells a variety of medical devices and equipment. The company has a market cap of 3.29B as of 2022 and a ROE of 5.86%. Medtronic’s products are used in a variety of medical procedures, including cardiac surgery, vascular surgery, and neurology.
Summary
Baxter International is a global healthcare company that provides a broad portfolio of products and services to both healthcare providers and patients. Despite this, the company’s net sales increased by 7% compared to the same period last year, buoyed by strong performance in its product offerings. Overall, the stock remains a good investment opportunity in the healthcare sector, as it continues its focus on providing quality healthcare solutions. Investors should monitor the company’s progress in delivering value-added products and services to healthcare providers and consumers.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
